Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto for cardiac remodeling after AF ablation
NCT03791723Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Jun 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of sacubitril + valsartan in Atrial fibrillation (AFib), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Left atrial size changes compared to baseline levels at 12 months. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03791723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791723.